Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2008
10/22/2008CN100427469C Quinoline derivatives as neutrophil elastase inhibitors and their use
10/22/2008CN100427465C N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses
10/21/2008US7439393 Phenethanolamine derivatives for treatment of respiratory diseases
10/21/2008US7439373 X-ray powder diffraction; antitumor agents
10/21/2008US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/21/2008US7439261 Process for the preparation of valsartan and intermediates thereof
10/21/2008US7439258 Viral polymerase inhibitors
10/21/2008US7439242 PPARγ modulators
10/21/2008US7439239 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; e.g. 10-(8-Methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenoxazine-3-carboxylic acid diethylamide
10/21/2008US7439207 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
10/21/2008CA2340734C Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
10/21/2008CA2336624C Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties
10/21/2008CA2330974C Energy transfer assay method and reagent
10/18/2008CA2682189A1 Thiazole and thiophene analogues, and their use in treating autoimmune diseases and cancers
10/16/2008WO2008124803A1 Substituted deuterium enriched thiophenes for the treatment of hypertension
10/16/2008WO2008124610A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008WO2008124075A1 Novel 2,3-benzodiazepine derivatives and their use as antipsychotic agents
10/16/2008WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008123017A1 Novel diamide derivative
10/16/2008WO2008122810A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008WO2008122784A1 Quinolines and their therapeutic use
10/16/2008WO2008122357A1 5-oxo-isoxazoles as inhibitors of lipases and phospholipases
10/16/2008WO2008122329A1 Uv-filter compounds
10/16/2008WO2008091752A3 Quinolone carboxylic acids, derivatives thereof, processes for their preparation and their use as antibacterial agents
10/16/2008WO2008086122A3 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5)
10/16/2008WO2008079988A3 Quinazolines for pdk1 inhibition
10/16/2008WO2008021745A3 Hepatitis c virus entry inhibitors
10/16/2008US20080255362 Cyclic amide derivative, and its production and use
10/16/2008US20080255352 Cyclic amide derivative, and its production and use
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255212 disorders of lipid and/or carbohydrate metabolism, metabolic disorders, central nervous system disorders; 3-{2-Chloro-4-[4-methyl-2-(4-trifluoromethyl-phenyl)-thiazole-5-ylmethoxy]-phenyl}-4H-[1,2,4]oxadiazole-5-one
10/16/2008US20080255211 cannabinoid receptors modulators; metabolic syndrome, obesity, hyperlipidemia, type II diabetes, atherosclerosis, substance addiction, liver cirrhosis, schizophrenia, sexual dysfunction, anxiety; 5-(5-(5-bromoselenophen-2-yl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-3-tert-butyl-1,2,4-oxadiazole
10/16/2008US20080255210 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
10/16/2008US20080255205 protein kinase receptors (like Tie-2 and Aurora) modulators; to treat cancer, inflammation and related disorders; to regulate active angiogenesis, cell-signal transduction; 5-(3-(1H-tetrazol-5-yl)pyridin-2-yloxy)-N-(3-chlorobenzyl)-2-fluorobenzamide
10/16/2008US20080255203 substituted oxadiazole and derivatives; novel allosteric modulators; nicotinic acetylcholine receptors modulators; central nervous system disorders; analgesics; 2,5-di(pyridin-3-yl)-1,3,4-oxadiazole
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255197 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255155 Inhibit protein tyrosine kinase; treating cell proliferative diseases and conditions; N-(6-(2-Fluoro-4-(4,4,4-trifluoro-3-(4-fluorophenylamino)butanamido)phenoxy)pyrimidin-4-yl)pyrrolidine-1-carboxamide
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255152 Diaryl ethers as opioid receptor antagonists
10/16/2008US20080255143 Inhibitors of Akt Activity
10/16/2008US20080255142 Substituted Piperidine Derivatives as Somatostatin Sst1 Receptor Antagonists
10/16/2008US20080255136 Pyrrolidones with anti-hiv activity
10/16/2008US20080255122 Derivatives of Isothiazol-3(2H)-One 1,1-Dioxides as Liver X Receptor Modulators
10/16/2008US20080255120 Substituted 2,5-heterocyclic derivatives
10/16/2008US20080255119 e.g. 5-[rac-cis-2,3-Bis-(4-chloro-phenyl)-5-oxo-2,3-dihydro-5H-imidazo[1,2-a]pyridine-1-sulfonyl]-2-fluoro-benzonitrile; inhibit the interaction of tumor suppressor MDM2 protein with a p53-like peptide; antiproliferative agent; cycle arrest in G1 and G2 phase
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255117 Sulfonyltryptophanols
10/16/2008US20080255116 Therapy for bacteria infections other than Mycibacterium infections; antibiotic resistance
10/16/2008US20080255115 (5Z)-5-{[4-(4-pyridinyl)-6-quinolinyl]methylidene}-1,3-thiazolidine-2,4-dione; autoimmune disorders, inflammatory, cardiovascular, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, sperm motility, transplantation rejection
10/16/2008US20080255114 2-aminobenzoxazole carboxamides as 5ht3 modulators
10/16/2008US20080255113 N-({1-[(cis-1,4-dihydroxycyclohexyl)methyl]piperidin-4-yl}methyl)-1-isopropyl-5-methyl-2-oxo-1, 2-dihydroquinoline-3-carboxamide ethanedioate; gastroesophageal reflux disease, non-ulcer dyspepsia, functional dyspepsia, irritable bowel syndrome
10/16/2008US20080255112 Pyrimidine-Substituted Benzimidazole Derivatives as Protein Kinase Inhibitors
10/16/2008US20080255111 (4'-{[2-(tert-Butoxycarbonyl)-3-hydroxy-4-(trifluoromethyl)benzyl]oxy}-1,1'-biphenyl-4-yl)acetic acid; vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, blood coagulation diseases
10/16/2008US20080255109 Antigonadotrophins; breast and prostate cancer, endometriosis, benign prostate hyperplasia; regulation of fertility; 4-(3-Chloro-4-{{(4-chloro-benzenesulfonyl)-methyl-amino]-methyl}-thiophene-2-carbonyl)-3,4-dihydro-2H-benzo[1,4]oxazine-2carboxylic acid (3-methyl-[1,2,4]oxadiazol-5-ylmethyl)-amide
10/16/2008US20080255105 Biphenyl Derivatives and Their Use in Treating Hepatitis C
10/16/2008US20080255095 Benzylamine analogues
10/16/2008US20080255086 Heterocyclic Derivatives
10/16/2008US20080255036 Substituted thiophenes
10/16/2008US20080254520 By controlling level of carbohydrates (starch, molasses) during Penicillium biodegradation; crystalline E-8-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-isobenzofuran-5-yl)-2,6-dimethyl-oct-6-enoic acid
10/16/2008CA2683857A1 Substituted deuterium enriched thiophenes for the treatment of hypertension
10/16/2008CA2683682A1 Phthalazinone derivatives and their use as medicament to treat cancer
10/16/2008CA2683431A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
10/16/2008CA2683180A1 Insecticidal aryl isoxazoline derivatives
10/16/2008CA2682891A1 5-oxoisoxazoles as inhibitors of lipases and phospholipases
10/16/2008CA2681861A1 Ornithine derivative
10/16/2008CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient
10/16/2008CA2680682A1 Quinolines and their therapeutic use
10/15/2008EP1980560A2 C-glycoside derivatives for the treatment of diabetes
10/15/2008EP1979345A2 Novel pyridine derivatives
10/15/2008EP1979339A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
10/15/2008EP1979338A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
10/15/2008EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
10/15/2008EP1979325A1 Morpholino pyrimidine derivatives and their use in therapy
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
10/15/2008EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
10/15/2008EP1979318A1 Amido compounds and their use as pharmaceuticals
10/15/2008EP1979315A2 Methods for treating hepatitis c
10/15/2008EP1979314A2 Indole sulfonamide modulators of progesterone receptors
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1685105B1 Allosteric modulators of metabotropic glutamate receptors
10/15/2008EP1567520B1 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
10/15/2008EP1537081B1 Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287731A Dioxazine- and oxdiazine-substituted arylamides
10/15/2008CN101287730A Glucuronate salt of a piperazine compound
10/15/2008CN101287729A GPCR agonists
10/15/2008CN101287727A Novel high affinity quinoline-based kinase ligands
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287722A Substituted piperazines as metabotropic glutamate receptor antagonists
10/15/2008CN101287721A 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use
10/15/2008CN101287715A Amide derivatives
10/15/2008CN101284810A Cyano-pyrrolidine and cyano-tetrahydrothiazole derivates
10/15/2008CN100425609C N-heteroarylnicotinamide derivatives
1 ... 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 ... 647